A head-to Head Comparison of the Pharmacodynamic Effects of Prasugrel Compared With Ticagrelor in Patients With Coronary Artery Disease
Phase of Trial: Phase II
Latest Information Update: 03 Feb 2016
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Pharmacodynamics
- 03 Feb 2016 Results published in the European Heart Journal
- 07 Aug 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 May 2014 Planned End Date changed from 1 Jan 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov.